The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Nonalcoholic fatty liver disease (NAFLD) represents a spectrum of disorders from a benign steatosis to hepatocellular carcinoma (HCC). Metabolic syndrome, mainly obesity, plays an important role, both as an independent risk factor and in the pathogenesis of NAFLD. With the progressive epidemics of obesity and diabetes mellitus, the prevalence of NAFLD and its associated complications is expected to increase dramatically. Therapeutic strategies for treating NAFLD and metabolic syndrome, particularly obesity, are continuously being refined. Their goal is the prevention of NAFLD by the management of risk factors, prevention of progression of the disease, as well as management of complications, ultimately preventing morbidity and mortality. Optimal management of NAFLD and metabolic syndrome requires a multidisciplinary collaboration between the government as well as the health system including the nutritionist, primary care physician, radiologist, hepatologist, oncologist, and transplant surgeon. An awareness of the clinical presentation, risk factors, pathogenesis, diagnosis, and management is of paramount importance to a radiologist, both from the clinical perspective as well as from the imaging standpoint. With expertise in imaging modalities as well as minimally invasive percutaneous endovascular therapies, radiologists play an essential role in the comprehensive management, which is highlighted in this article, with cases from our practice. We also briefly discuss transarterial embolization of the left gastric artery (LGA), a novel method that promises to have an enormous potential in the minimally invasive management of obesity, with details of a case from our practice.

Original languageEnglish (US)
Article number32
JournalJournal of Clinical Imaging Science
Volume5
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Obesity
Play Therapy
Nutritionists
Primary Care Physicians
Disease Management
Disease Progression
Non-alcoholic Fatty Liver Disease
Radiologists
Hepatocellular Carcinoma
Stomach
Diabetes Mellitus
Arteries
Morbidity
Transplants
Mortality
Health
Therapeutics

Keywords

  • Hepatocellular carcinoma
  • left gastric artery embolization
  • metabolic syndrome
  • nonalcoholic fatty liver disease

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

The Global Nonalcoholic Fatty Liver Disease Epidemic : What a Radiologist Needs to Know. / Pereira, Keith; Salsamendi, Jason; Casillas, Victor.

In: Journal of Clinical Imaging Science, Vol. 5, No. 1, 32, 01.01.2015.

Research output: Contribution to journalArticle

@article{09e1569eeca741cbaa857d76d19c2113,
title = "The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know",
abstract = "Nonalcoholic fatty liver disease (NAFLD) represents a spectrum of disorders from a benign steatosis to hepatocellular carcinoma (HCC). Metabolic syndrome, mainly obesity, plays an important role, both as an independent risk factor and in the pathogenesis of NAFLD. With the progressive epidemics of obesity and diabetes mellitus, the prevalence of NAFLD and its associated complications is expected to increase dramatically. Therapeutic strategies for treating NAFLD and metabolic syndrome, particularly obesity, are continuously being refined. Their goal is the prevention of NAFLD by the management of risk factors, prevention of progression of the disease, as well as management of complications, ultimately preventing morbidity and mortality. Optimal management of NAFLD and metabolic syndrome requires a multidisciplinary collaboration between the government as well as the health system including the nutritionist, primary care physician, radiologist, hepatologist, oncologist, and transplant surgeon. An awareness of the clinical presentation, risk factors, pathogenesis, diagnosis, and management is of paramount importance to a radiologist, both from the clinical perspective as well as from the imaging standpoint. With expertise in imaging modalities as well as minimally invasive percutaneous endovascular therapies, radiologists play an essential role in the comprehensive management, which is highlighted in this article, with cases from our practice. We also briefly discuss transarterial embolization of the left gastric artery (LGA), a novel method that promises to have an enormous potential in the minimally invasive management of obesity, with details of a case from our practice.",
keywords = "Hepatocellular carcinoma, left gastric artery embolization, metabolic syndrome, nonalcoholic fatty liver disease",
author = "Keith Pereira and Jason Salsamendi and Victor Casillas",
year = "2015",
month = "1",
day = "1",
doi = "10.4103/2156-7514.157860",
language = "English (US)",
volume = "5",
journal = "Journal of Clinical Imaging Science",
issn = "2156-7514",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "1",

}

TY - JOUR

T1 - The Global Nonalcoholic Fatty Liver Disease Epidemic

T2 - What a Radiologist Needs to Know

AU - Pereira, Keith

AU - Salsamendi, Jason

AU - Casillas, Victor

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Nonalcoholic fatty liver disease (NAFLD) represents a spectrum of disorders from a benign steatosis to hepatocellular carcinoma (HCC). Metabolic syndrome, mainly obesity, plays an important role, both as an independent risk factor and in the pathogenesis of NAFLD. With the progressive epidemics of obesity and diabetes mellitus, the prevalence of NAFLD and its associated complications is expected to increase dramatically. Therapeutic strategies for treating NAFLD and metabolic syndrome, particularly obesity, are continuously being refined. Their goal is the prevention of NAFLD by the management of risk factors, prevention of progression of the disease, as well as management of complications, ultimately preventing morbidity and mortality. Optimal management of NAFLD and metabolic syndrome requires a multidisciplinary collaboration between the government as well as the health system including the nutritionist, primary care physician, radiologist, hepatologist, oncologist, and transplant surgeon. An awareness of the clinical presentation, risk factors, pathogenesis, diagnosis, and management is of paramount importance to a radiologist, both from the clinical perspective as well as from the imaging standpoint. With expertise in imaging modalities as well as minimally invasive percutaneous endovascular therapies, radiologists play an essential role in the comprehensive management, which is highlighted in this article, with cases from our practice. We also briefly discuss transarterial embolization of the left gastric artery (LGA), a novel method that promises to have an enormous potential in the minimally invasive management of obesity, with details of a case from our practice.

AB - Nonalcoholic fatty liver disease (NAFLD) represents a spectrum of disorders from a benign steatosis to hepatocellular carcinoma (HCC). Metabolic syndrome, mainly obesity, plays an important role, both as an independent risk factor and in the pathogenesis of NAFLD. With the progressive epidemics of obesity and diabetes mellitus, the prevalence of NAFLD and its associated complications is expected to increase dramatically. Therapeutic strategies for treating NAFLD and metabolic syndrome, particularly obesity, are continuously being refined. Their goal is the prevention of NAFLD by the management of risk factors, prevention of progression of the disease, as well as management of complications, ultimately preventing morbidity and mortality. Optimal management of NAFLD and metabolic syndrome requires a multidisciplinary collaboration between the government as well as the health system including the nutritionist, primary care physician, radiologist, hepatologist, oncologist, and transplant surgeon. An awareness of the clinical presentation, risk factors, pathogenesis, diagnosis, and management is of paramount importance to a radiologist, both from the clinical perspective as well as from the imaging standpoint. With expertise in imaging modalities as well as minimally invasive percutaneous endovascular therapies, radiologists play an essential role in the comprehensive management, which is highlighted in this article, with cases from our practice. We also briefly discuss transarterial embolization of the left gastric artery (LGA), a novel method that promises to have an enormous potential in the minimally invasive management of obesity, with details of a case from our practice.

KW - Hepatocellular carcinoma

KW - left gastric artery embolization

KW - metabolic syndrome

KW - nonalcoholic fatty liver disease

UR - http://www.scopus.com/inward/record.url?scp=84940852547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940852547&partnerID=8YFLogxK

U2 - 10.4103/2156-7514.157860

DO - 10.4103/2156-7514.157860

M3 - Article

AN - SCOPUS:84940852547

VL - 5

JO - Journal of Clinical Imaging Science

JF - Journal of Clinical Imaging Science

SN - 2156-7514

IS - 1

M1 - 32

ER -